Helen Matthews

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Rethinking our strategies to develop disease-modifying therapies for Parkinson's: Time for combination therapies?

Rethinking our strategies to develop disease-modifying therapies for Parkinson's: Time for combination therapies?

Journal: Journal of Parkinson's disease

Published: April 21, 2026

Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease.

Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease.

Journal: Journal of neurology

Published: December 11, 2025

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.

Journal: Lancet (London, England)

Published: October 07, 2024

A Coalition to Advance Treatments for Parkinson's Disease, Dementia with Lewy Bodies, and Related Disorders.

A Coalition to Advance Treatments for Parkinson's Disease, Dementia with Lewy Bodies, and Related Disorders.

Journal: Journal of Parkinson's disease

Published: August 09, 2024

Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation Protocol.

Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation Protocol.

Journal: Journal of Parkinson's disease

Published: May 03, 2024

Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials Initiative.

Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials Initiative.

Journal: Journal of Parkinson's disease

Published: April 05, 2024

Self-Image in Women with Parkinson's Disease.

Self-Image in Women with Parkinson's Disease.

Journal: Journal of Parkinson's disease

Published: March 13, 2023

Medical Research Charities and Biopharmaceutical Companies as Partners in Patient-Centred R&D.

Medical Research Charities and Biopharmaceutical Companies as Partners in Patient-Centred R&D.

Journal: Pharmaceutical medicine

Published: July 07, 2022

Waiting for PARIS-A Biological Target in Search of a Drug.

Waiting for PARIS-A Biological Target in Search of a Drug.

Journal: Journal of Parkinson's disease

Published: November 08, 2021

Seeking progress in disease modification in Parkinson disease.

Seeking progress in disease modification in Parkinson disease.

Journal: Parkinsonism & related disorders

Published: May 14, 2021

Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.

Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.

Journal: JAMA neurology

Published: December 14, 2020

Protocol for PD SENSORS: Parkinson's Disease Symptom Evaluation in a Naturalistic Setting producing Outcome measuRes using SPHERE technology. An observational feasibility study of multi-modal multi-sensor technology to measure symptoms and activities of daily living in Parkinson's disease.

Protocol for PD SENSORS: Parkinson's Disease Symptom Evaluation in a Naturalistic Setting producing Outcome measuRes using SPHERE technology. An observational feasibility study of multi-modal multi-sensor technology to measure symptoms and activities of daily living in Parkinson's disease.

Journal: BMJ open

Published: December 01, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026